Advanced search
Publication Cover
Infection and Drug Resistance Volume 12, 2019 - Issue
Submit an article Journal homepage
122
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt

Ahmed Mohamed Saleh1 Tropical Medicine Department, Fayoum University, Al Fayyum, Egypt
,
Essam Ali Hassan1 Tropical Medicine Department, Fayoum University, Al Fayyum, Egypt
,
Ahmed Ali Gomaa1 Tropical Medicine Department, Fayoum University, Al Fayyum, Egypt
,
Tamer Mahmoud El Baz2 Endemic Medicine Department, Cairo University, Giza, Egypt
,
Mohamed El-Abgeegy3 Liver Transplantation Team, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt
,
Mohamed Ismail Seleem3 Liver Transplantation Team, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt
,
Yousry Esam-Eldin Abo-amer4 Hepatology, Gastroenterology, and Infectious Diseases Department, Mahala Hepatology Teaching Hospital, Gharbia, Egypt
,
Heba Fadl Elsergany3 Liver Transplantation Team, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt
,
Eman Ibrahim El-Desoki Mahmoud3 Liver Transplantation Team, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt
&
Sherief Abd-Elsalam5 Tropical Medicine Department, Tanta University, Tanta, EgyptCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4366-2218
ORCID Icon show all
Pages 2277-2282 | Published online: 24 Jul 2019

References

  • Graziadei I, Zoller H, Fickert P, et al. Indications for liver transplantation in adults. Wien Klin Wochenschr. 2016;128:679–690. doi:10.1007/s00508-016-1046-127590261
  • Sagmeister M, Mullhaupt B, Kadry Z, Kullak-Ublick GA, Clavien PA, Renner EL. Cost-effectiveness of cadaveric and living-donor liver transplantation. Transplantation. 2002;73:616–622.11889442
  • Jalan R, Gines P, Olson J, et al. Acute-on- chronic liver failure. J Hepatol. 2012;57:1336–1348. doi:10.1016/j.jhep.2012.06.02622750750
  • Acevedo J, Fernandez J. New determinants of prognosis in bacterial infections in cirrhosis. World J Gastroenterol. 2014;20:7252–7259. doi:10.3748/wjg.v20.i23.725224966596
  • Reddy KR, O’Leary JG, Kamath PS, et al. High risk of delisting or death in liver transplant candidates following infections: results from the North American Consortium for the study of end-stage liver disease. Liver Transpl. 2015;21:881–888. doi:10.1002/lt.2413925845966
  • Mah A, Wright A. Infectious considerations in the pre-transplant evaluation of cirrhotic patients awaiting orthotopic liver transplantation. Curr Infect Dis Rep. 2016;18:4. doi:10.1007/s11908-015-0514-526743200
  • Moreau R, Jalan R, Gines P, et al. Acute-on chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1441426–1441437.
  • Ahmed OA, Kaisar HH, Hawash N, et al. Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in treatment of a cohort of Egyptian patients with hepatitis C virus infection. Infect Disord Drug Targets. 2017;17(2):95–100. doi:10.2174/187152651766617041714321628413993
  • Abd-Elsalam S, Sharaf-Eldin M, Soliman S, Elfert A, Badawi R, Ahmad YK. Efficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practice. Arch Virol. 2018;163(1):51–66. doi:10.1007/s00705-017-3573-028983675
  • Ahmed OA, Kaisar HH, Badawi R, et al. Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection. Infect Drug Resist. 2018;11:295–298. doi:10.2147/IDR.S15306029535545
  • Ahmed OA, Elsebaey MA, Fouad MHA, et al. Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection. Infect Drug Resist. 2018;11:441–445. doi:10.2147/IDR.S16059329628768
  • Ahmed OA, Safwat E, Khalifa MO, et al. Sofosbuvir plus daclatasvir in treatment of chronic hepatitis C genotype 4 infection in a Cohort of Egyptian Patients: an experiment the size of Egyptian village. Int J Hepatol. 2018;2018:9616234. doi:10.1155/2018/961623429755792
  • Abd-Elsalam S, Badawi R, Elnawasany S, et al. Sofosbuvir, pegylated interferon and ribavirin in treatment of an Egyptian cohort with hepatitis C virus infection in real life clinical practice. Infect Disord Drug Targets. 2018. doi:10.2174/1871526518666180912121835
  • Sharaf-Eldin M, Bediwy AS, Kobtan A, et al. Pigtail catheter: a less invasive option for pleural drainage in Egyptian patients with recurrent hepatic hydrothorax. Gastroenterol Res Pract. 2016;2016:4013052. doi:10.1155/2016/401305227340399
  • Sun HY, Cacciarelli TV, Sing N. Impact of pretransplant infections on clinical outcomes of liver transplant recipients. Liver Transpl. 2010;16:222–228. doi:10.1002/lt.2198220104499
  • Fernandez J, Navasa M, Gómez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35(1):140–148. doi:10.1053/jhep.2002.3008211786970
  • Thévenot T, Bureau C, Oberti F, et al. Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial. Journal of Hepatology. 2014;60:S29. doi:10.1016/j.jhep.2014.11.017
  • Garcia-Tsao G. Bacterial infections in cirrhosis. Can J Gastroenterol. 2004;18:405–406. doi:10.1155/2004/76961515190398
  • Lin KH, Liu JW, Chen CL, et al. Impacts of pretransplant infections on clinical outcomes of patients with acute-on-chronic liver failure who received living-donor liver transplantation. PLoS ONE. 2013;8(9):e72893. doi:10.1371/journal.pone.007289324023787
  • Bertuzzo VR, Giannella M, Cucchetti A, et al. Impact of preoperative infection on outcome after liver transplantation. British_Journal_of_Surgery. 2017;104(2):e172–e181. doi:10.1002/bjs.1044928121031
  • Hara T, Soyama A, Takatsuki M, et al. The impact of treated bacterial infections within one month before living donor liver transplantation in adults. Ann Transplant. 2014;19:674–679. doi:10.12659/AOT.89209525536330

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.